Try our Advanced Search for more refined results

IN RE: ALLERGAN BIOCELL TEXTURED BREAST IMPLANT PRODUCTS LIABILITY LITIGATION

  1. August 10, 2022

    Allergan Must Comply With Implant MDL Discovery

    Allergan can't delay handing over communications its sales representatives had with physicians regarding the safety and efficacy of its textured breast implants, a New Jersey federal judge has ruled, saying the records are necessary at this point in the multidistrict litigation.

  2. March 19, 2021

    Allergan Must Face Breast Implant, Class Claims In MDL

    Allergan came up short Friday in its attempt to escape claims in multidistrict litigation that the company hid the cancer risks of its textured breast implants, with a New Jersey federal judge saying certain claims are not preempted by federal law and class allegations are still in play.

  3. January 06, 2021

    Allergan Says Federal Law Preempts Breast Implant Claims

    Allergan USA Inc. is asking a New Jersey federal court to throw out claims in multidistrict litigation that it hid reports of serious injuries resulting from its breast implants, saying the consolidated complaint's allegations are preempted by federal law.

  4. October 16, 2020

    Patients Say Ill. Allergan Ruling Is Irrelevant To Implant MDL

    Patients accusing Allergan Inc. of making an unsafe breast implant argued Thursday that Allergan's recent defeat of an Illinois suit over the implant won't help a New Jersey federal judge decide whether to dismiss their suits from multidistrict litigation over the product.

  5. October 08, 2020

    Allergan Implant Patients Say State Claims Should Proceed

    A group of patients alleging that Allergan Inc.'s breast implants were defective and dangerous are pushing back against a bid to dismiss their complaint, saying their state law claims are parallel to federal law requirements and aren't seeking to impose more restrictions than the U.S. Food and Drug Administration's regulations.

  6. August 17, 2020

    Allergan Wins Bid To ID Breast Implant Patients In MDL

    A New Jersey federal judge ruled that patients accusing Allergan Inc. of hiding the health risks of its textured breast implants must reveal their identities in court filings, according to an order made public Monday, reasoning that their potential embarrassment doesn't justify anonymity in the multidistrict litigation.

  7. August 10, 2020

    Allergan Says Breast Implant MDL Claims Are Preempted

    Allergan Inc. is urging a New Jersey federal court to throw out claims in multidistrict litigation alleging that it hid the health risks of its textured breast implants, saying that because the implants' design, manufacture and marketing were approved by the Food and Drug Administration, the claims are preempted by federal law.

  8. January 07, 2020

    Allergan Accused Of Playing Dirty In Breast Implant MDL

    A group of women claiming Allergan Inc. hid the cancer risks of its breast implants told a New Jersey federal court that the company is tricking women into giving up their right to sue by hiding a release agreement in a warranty reimbursement offer.

  9. December 18, 2019

    Allergan Breast Implant Risk MDL Heading To NJ

    The Judicial Panel on Multidistrict Litigation on Wednesday sent four suits alleging that Allergan hid the cancer risks of its textured breast implants to federal court in New Jersey, where the company is headquartered.